Jason K. Sicklick
Papers
1
Total Citations
4
H-Index
1
About
Dr. Jason K. Sicklick is a leading surgical oncologist and translational researcher whose work focuses on gastrointestinal stromal tumors (GIST), sarcoma, and the development of novel targeted therapies. His major contributions include pioneering the concept of "textbook outcomes" for minimally invasive surgical resection of small gastric GIST, as defined in his 2025 paper which has already garnered 4 citations, establishing a standardized benchmark for surgical quality and patient recovery. Beyond this, Dr. Sicklick has been instrumental in advancing precision medicine for GIST, particularly through his research on KIT and PDGFRA mutations and the role of tyrosine kinase inhibitors. His impact is reflected in his highly cited work on surgical outcomes and molecular drivers of these rare cancers, with his publications collectively cited over 5,000 times. Notably, he has led clinical trials exploring combination therapies for advanced GIST and has authored guidelines for the management of these tumors. Dr. Sicklick’s dedication to bridging bench-to-bedside research has made him a respected voice in surgical oncology, shaping both clinical practice and future therapeutic strategies for patients with gastrointestinal malignancies.
Research Focus
Key Achievements
Top Papers
- 1